Hongyuan Xu

发表

Impaired Restoration of Global Protein Synthesis Contributes to Increased Vulnerability to Acute ER Stress Recovery in Huntington’s Disease

E. Capobianco, Hongyuan Xu, Johanna Bensalel, 2021, Cellular and Molecular Neurobiology.

Bioinformatics and In Silico Findings Uncover Bio-Targets of Calycosin Against Heart Failure and Diabetes Mellitus

Hongyuan Xu, Chao Guo, Bin Yang, 2022, Frontiers in Endocrinology.

Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model

Hongyuan Xu, Jang-Yen Wu, H. Prentice, 2020, Journal of Biomedical Science.

Biotargets for mediation of arsenic–induced coronary heart disease by calycosin

Hongyuan Xu, Yizhao Chen, Bin Yang, 2022, Food and Agricultural Immunology.

Characterization of huntingtin interactomes and their dynamic responses in living cells by proximity proteomics

E. Capobianco, Hongyuan Xu, Johanna Bensalel, 2022, Journal of neurochemistry.

RNA-seq analysis reveals significant transcriptome changes in huntingtin-null human neuroblastoma cells

E. Capobianco, Hongyuan Xu, Johanna Bensalel, 2021, BMC Medical Genomics.

Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model

Hongyuan Xu, Jang-Yen Wu, H. Prentice, 2020, Journal of Biomedical Science.

The Role of NMDA Receptor Partial Antagonist, Carbamathione, as a Therapeutic Agent for Transient Global Ischemia

W. Shen, Hongyuan Xu, Jang-Yen Wu, 2023, Biomedicines.

Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington’s disease

Hongyuan Xu, Ian D. Gaudet, Emily Gordon, 2024, Journal of neuroinflammation.